A Retrospective Cohort Study to Assess the Long-Term Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Adults with Moderate to Severe Rheumatoid Arthritis in the Course of Routine Clinical Care (I4V-MC-B004)First published 03/04/2019 Last updated 15/02/2024 EU PAS number: EUPAS25145StudyFinalised